Antag Therapeutics
DenmarkEntry
2017
Hold
9yr
Status
Active
Who owns Antag Therapeutics?
Antag Therapeutics is currently owned by Novo Holdings through Novo Holdings Seed Investments (1999 vintage), since 2017. Across its history, Antag Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-18
Most recent investor
Novo HoldingsNovo Holdings Seed Investments · 1999 · VC
2 ownership periods · full history below
Key facts
HQDenmark
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2017 · present
Novo HoldingsActive
2017 · present(9yr) · Novo Holdings Seed Investments · 1999 · VC
EifoActive
2024 · present(2yr) · EIFO (direct equity) · 1992 · VC
More from Novo Holdings Seed Investments
Other portfolio companies in the same fund.
US
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack Antag Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Antag Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Antag Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue